Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study in ...

Older adults and newborn babies are among those most at risk, leading to serious cases of pneumonia, a high number of ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

RAPID CITY, S.D. - With fall approaching, not only will the days become darker and cooler, but cold and flu season will also ...